NASDAQ · Medical - Diagnostics & Research

Mainz Biomed B.V. (MYNZ) Stock

$3.59 +0.84% NASDAQ: MYNZ Healthcare

Mainz Biomed B.V. is a German company specializing in molecular genetics for the development of cancer diagnostics.

Valuation

MetricValue
Price$3.59
Market Cap$14.69M
P/E Ratio-2.93
P/B Ratio3.24
P/S Ratio55.00
EPS (TTM)$-2.70
52-Week High$5.34
52-Week Low$0.55
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-325.93%
ROA-109.14%
ROCE-170.15%
Gross Margin100.00%
Operating Margin-1300.00%
Net Margin-1600.00%
Debt/Equity0.03
Current Ratio2.11

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$1.0M$1.0M$1.0M$1.0M
Operating Profit$-10.0M$-26.0M$-27.0M$-19.0M$-13.0M
Net Profit$-12.0M$-26.0M$-26.0M$-22.0M$-16.0M
EPS$-1.67$-1.87$-1.62$-22.36$-2.70
Op Margin-1684.4%-4990.6%-2975.5%-2091.2%-2513.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$10.0M$20.0M$15.0M$13.0M$5.0M
Total Liabilities$4.0M$6.0M$12.0M$7.0M$5.0M
Cash$9.0M$17.0M$7.0M$6.0M$1.0M
Borrowings$3.0M$3.0M$7.0M$3.0M$3.0M

Latest News

O'Shaughnessy Ventures Backs Astrophysicist Challenging Assumptions About How Much Dark Matter the Universe Needs PR Newswire · Jul 16, 2026 Racing America and PerfectVision Team Up to Bring High-Speed Internet to Racing's Hometowns PR Newswire · Jul 16, 2026 AEROCOR Releases First Edition of Phenom 100 Buyer's Guide PR Newswire · Jul 16, 2026 What NYC artist says about coming Charlie Kirk statue USA TODAY · Jul 16, 2026 Bitcoin and ethereum prices today, Thursday, July 16, 2026: Prices rise, ethereum becomes 'increasingly compelling' Yahoo Personal Finance · Jul 16, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-3.0M$-15.0M$-22.0M$-17.0M$-11.0M
Investing Cash Flow$1.0M$-1.0M$-4.0M$0$-1.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$9.0M$8.0M$-10.0M$-1.0M$-5.0M
Free Cash Flow$-3.0M$-15.0M$-24.0M$-17.0M$-11.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.03
EV / EBITDA-1.53
FCF Yield-35.08%
Quick Ratio2.11
Interest Coverage-39.06
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BNBX $0.16 +0.00% 0.00 $210492 0.00%
BNGO $1.07 +0.94% -1.16 $12.28M 0.00%
CHEKCheck-Cap Ltd. $1.86 +1.64% -0.43 $10.88M 0.00%
FLGCFlora Growth Corp. $7.79 -32.14% -0.54 $4.23M 0.00%
GBSGBS Inc. $0.47 -1.58% -0.18 $433577 0.00%

About Mainz Biomed B.V.

Mainz Biomed B.V. is a German company specializing in molecular genetics for the development of cancer diagnostics. The firm engineers both in-vitro diagnostic (IVD) tools and assays designed exclusively for research, primarily catering to clinical applications within human genetics. Among its key offerings is ColoAlert, a screening test for detecting colorectal cancer. Additionally, they are developing PancAlert, a promising product candidate intended for pancreatic cancer screening. Beyond cancer, Mainz Biomed also provides GenoStrip, a molecular genetic solution for identifying pathogens in various environments. Established in 2008, the company maintains its headquarters in Mainz, Germany.

Mainz Biomed B.V. is headquartered in DE.

Mainz Biomed B.V. (MYNZ) stock trades at $3.59 with a market capitalization of $14.69M. The stock is valued at a price-to-earnings (P/E) ratio of -2.93, price-to-book of 3.24, price-to-sales of 55.00. Over the past 52 weeks the stock has ranged between $0.55 and $5.34, and currently trades 32.8% below its 52-week high.

On profitability, Mainz Biomed B.V. generates a return on equity (ROE) of -325.93%, return on capital employed of -170.15%, an operating margin of -1300.00%, a net profit margin of -1600.00%.

Official website: mainzbiomed.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides